Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48


17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study.

Collin LJ, Ulrichsen SP, Ahern TP, Goodman M, McCullough LE, Waller LA, Bang Christensen K, Damkier P, Hamilton-Dutoit S, Lauridsen KL, Yacoub R, Christiansen PM, Ejlertsen B, Sørensen HT, Cronin-Fenton DP, Lash TL.

Acta Oncol. 2019 Oct 31:1-5. doi: 10.1080/0284186X.2019.1684560. [Epub ahead of print] No abstract available.


RE.: Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer.

Harborg S, Cronin-Fenton DP, Borgquist S.

Breast Cancer Res Treat. 2019 Oct;177(3):771-772. doi: 10.1007/s10549-019-05337-2. Epub 2019 Jul 4. No abstract available.


Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study.

Ahern TP, Broe A, Lash TL, Cronin-Fenton DP, Ulrichsen SP, Christiansen PM, Cole BF, Tamimi RM, Sørensen HT, Damkier P.

J Clin Oncol. 2019 Jul 20;37(21):1800-1809. doi: 10.1200/JCO.18.02202. Epub 2019 Apr 17.


Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.

Falstie-Jensen AM, Kjærsgaard A, Lorenzen EL, Jensen JD, Reinertsen KV, Dekkers OM, Ewertz M, Cronin-Fenton DP.

Breast Cancer Res. 2019 Mar 22;21(1):44. doi: 10.1186/s13058-019-1122-3.


Expression of survivin does not appear to influence breast cancer recurrence risk.

Collin LJ, Cronin-Fenton DP, Ahern TP, Christensen KB, Damkier P, Hamilton-Dutoit S, Kjaersgaard A, Lauridsen KL, Yacoub R, Christiansen P, Sørensen HT, Lash TL.

Acta Oncol. 2019 Feb;58(2):154-161. doi: 10.1080/0284186X.2018.1503419. Epub 2018 Oct 23.


Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark.

Collin LJ, Cronin-Fenton DP, Ahern TP, Christiansen PM, Damkier P, Ejlertsen B, Hamilton-Dutoit S, Kjærsgaard A, Silliman RA, Sørensen HT, Lash TL.

BMJ Open. 2018 Aug 1;8(7):e021805. doi: 10.1136/bmjopen-2018-021805.


Tamoxifen and CYP2D6: A Controversy in Pharmacogenetics.

Cronin-Fenton DP, Damkier P.

Adv Pharmacol. 2018;83:65-91. doi: 10.1016/bs.apha.2018.03.001. Epub 2018 May 7. Review.


Association of Statin Use With Overall and Cancer Survival.

Ahern TP, Borgquist S, Cronin-Fenton DP.

JAMA Oncol. 2018 Jul 1;4(7):1015-1016. doi: 10.1001/jamaoncol.2018.0733. No abstract available.


Re: Beta Blockers and Improved Progression-Free Survival in Patients With Advanced HER2 Negative Breast Cancer.

Sørensen GV, Cronin-Fenton DP, Sørensen HT, Damkier P, Ejlertsen B, Christiansen PM, Lash TL, Ahern TP.

Epidemiology. 2018 Sep;29(5):e39-e40. doi: 10.1097/EDE.0000000000000853. No abstract available.


Breast cancer recurrence after reoperation for surgical bleeding.

Pedersen RN, Bhaskaran K, Heide-Jørgensen U, Nørgaard M, Christiansen PM, Kroman N, Sørensen HT, Cronin-Fenton DP.

Br J Surg. 2017 Nov;104(12):1665-1674. doi: 10.1002/bjs.10592. Epub 2017 Aug 7.


Clinical outcomes of female breast cancer according to BRCA mutation status.

Cronin-Fenton DP, Kjærsgaard A, Nørgaard M, Pedersen IS, Thomassen M, Kaye JA, Gutierrez L, Telford C, Lewis J, Tyczynski JE, Sørensen HT.

Cancer Epidemiol. 2017 Aug;49:128-137. doi: 10.1016/j.canep.2017.05.016. Epub 2017 Jun 8.


Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study.

Cronin-Fenton DP, Kjærsgaard A, Ahern TP, Mele M, Ewertz M, Hamilton-Dutoit S, Christiansen PM, Ejlertsen B, Sørensen HT, Lash TL, Silliman RA.

Acta Oncol. 2017 Sep;56(9):1155-1160. doi: 10.1080/0284186X.2017.1327720. Epub 2017 Jun 6.


Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.

Klebaner D, Hamilton-Dutoit S, Ahern T, Crawford A, Jakobsen T, Cronin-Fenton DP, Damkier P, Janssen E, Kjaersgaard A, Ording AG, Søiland H, Sørensen HT, Lash TL, Hellberg Y.

PLoS One. 2017 Mar 16;12(3):e0171453. doi: 10.1371/journal.pone.0171453. eCollection 2017.


Cytochrome P-450 2D6 (CYP2D6) Genotype and Breast Cancer Recurrence in Tamoxifen-Treated Patients: Evaluating the Importance of Loss of Heterozygosity.

Ahern TP, Hertz DL, Damkier P, Ejlertsen B, Hamilton-Dutoit SJ, Rae JM, Regan MM, Thompson AM, Lash TL, Cronin-Fenton DP.

Am J Epidemiol. 2017 Jan 15;185(2):75-85. doi: 10.1093/aje/kww178. Epub 2016 Dec 17. Review.


Pak1, adjuvant tamoxifen therapy, and breast cancer recurrence risk in a Danish population-based study.

Ahern TP, Cronin-Fenton DP, Lash TL, Sørensen HT, Ording AG, Hamilton-Dutoit SJ, Hellberg Y.

Acta Oncol. 2016 Jun;55(6):734-41. doi: 10.3109/0284186X.2016.1150606. Epub 2016 Apr 8.


Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.

Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, Lash TL, Christiansen P, Ejlertsen B, Sørensen HT.

Epidemiology. 2016 Jul;27(4):586-93. doi: 10.1097/EDE.0000000000000480.


Opioids and breast cancer recurrence: A Danish population-based cohort study.

Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, Lash TL, Christiansen PM, Ejlertsen B, Sjøgren P, Kehlet H, Sørensen HT.

Cancer. 2015 Oct 1;121(19):3507-14. doi: 10.1002/cncr.29532. Epub 2015 Jul 24.


Glucocorticoid prescriptions and breast cancer recurrence: a Danish nationwide prospective cohort study.

Lietzen LW, Ahern T, Christiansen P, Jensen AB, Sørensen HT, Lash TL, Cronin-Fenton DP.

Ann Oncol. 2014 Dec;25(12):2419-25. doi: 10.1093/annonc/mdu453. Epub 2014 Sep 15.


Statins and breast cancer prognosis: evidence and opportunities.

Ahern TP, Lash TL, Damkier P, Christiansen PM, Cronin-Fenton DP.

Lancet Oncol. 2014 Sep;15(10):e461-8. doi: 10.1016/S1470-2045(14)70119-6. Review.


Manganese superoxide dismutase and breast cancer recurrence: a Danish clinical registry-based case-control study, and a meta-analysis.

Cronin-Fenton DP, Christensen M, Lash TL, Ahern TP, Pedersen L, Garne JP, Ewertz M, Autrup H, Sørensen HT, Hamilton-Dutoit S.

PLoS One. 2014 Jan 31;9(1):e87450. doi: 10.1371/journal.pone.0087450. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e92620.


Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy.

Cronin-Fenton DP, Damkier P, Lash TL.

Future Oncol. 2014 Jan;10(1):107-22. doi: 10.2217/fon.13.168. Review.


Comorbidity and survival of Danish breast cancer patients from 2000-2011: a population-based cohort study.

Ording AG, Cronin-Fenton DP, Jacobsen JB, Nørgaard M, Thomsen RW, Christiansen P, Søgaard M.

Clin Epidemiol. 2013 Nov 1;5(Suppl 1):39-46. doi: 10.2147/CLEP.S47152. eCollection 2013.


Methods and rationale used in a matched cohort study of the incidence of new primary cancers following prostate cancer.

Cronin-Fenton DP, Antonsen S, Cetin K, Acquavella J, Daniels A, Lash TL.

Clin Epidemiol. 2013 Oct 31;5:429-37. doi: 10.2147/CLEP.S49713. eCollection 2013.


Mortality and incidence of new primary cancers in men with prostate cancer: a Danish population-based cohort study.

Cronin-Fenton DP, Antonsen S, Cetin K, Daniels A, Borre M, Acquavella J, Lash TL.

Cancer Epidemiol. 2013 Oct;37(5):562-8. doi: 10.1016/j.canep.2013.06.002. Epub 2013 Jul 3.


Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.

Sørensen GV, Ganz PA, Cole SW, Pedersen LA, Sørensen HT, Cronin-Fenton DP, Garne JP, Christiansen PM, Lash TL, Ahern TP.

J Clin Oncol. 2013 Jun 20;31(18):2265-72. doi: 10.1200/JCO.2012.43.9190. Epub 2013 May 6.


Use of glucocorticoids and risk of breast cancer: a Danish population-based case-control study.

Sørensen GV, Cronin-Fenton DP, Sørensen HT, Ulrichsen SP, Pedersen L, Lash TL.

Breast Cancer Res. 2012 Feb 3;14(1):R21.


Factors associated with concordant estrogen receptor expression at diagnosis and centralized re-assay in a Danish population-based breast cancer study.

Cronin-Fenton DP, Hellberg Y, Lauridsen KL, Ahern TP, Garne JP, Rosenberg C, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S.

Acta Oncol. 2012 Feb;51(2):254-61. doi: 10.3109/0284186X.2011.633556. Epub 2011 Nov 30.


Pancreatic cancer survival in central and northern Denmark from 1998 through 2009: a population-based cohort study.

Cronin-Fenton DP, Erichsen R, Mortensen FV, Dikinis S, Nørgaard M, Jacobsen J.

Clin Epidemiol. 2011;3 Suppl 1:19-25. doi: 10.2147/CLEP.S20611. Epub 2011 Jul 20.


Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.

Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL.

J Natl Cancer Inst. 2011 Oct 5;103(19):1461-8. doi: 10.1093/jnci/djr291. Epub 2011 Aug 2.


Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors.

Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Søiland H, Gjerde J, Garne JP, Rosenberg CL, Silliman RA, Sørensen HT, Lash TL, Hamilton-Dutoit S.

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1937-43. doi: 10.1158/1055-9965.EPI-11-0419. Epub 2011 Jul 12.


Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.

Cronin-Fenton DP, Lash TL.

Expert Rev Clin Pharmacol. 2011 May;4(3):363-77. doi: 10.1586/ecp.11.18. Review.


Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue.

Ahern TP, Christensen M, Cronin-Fenton DP, Lunetta KL, Rosenberg CL, Sørensen HT, Lash TL, Hamilton-Dutoit S.

Clin Epidemiol. 2010 Oct 22;2:241-6. doi: 10.2147/CLEP.S13811.


Antidepressant use and colorectal cancer risk: a Danish population-based case-control study.

Cronin-Fenton DP, Riis AH, Lash TL, Dalton SO, Friis S, Robertson D, Sørensen HT.

Br J Cancer. 2011 Jan 4;104(1):188-92. doi: 10.1038/sj.bjc.6605911. Epub 2010 Sep 28. Erratum in: Br J Cancer. 2011 May 24;104(11):1804.


Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006.

Cronin-Fenton DP, Søndergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, Baron JA, Sørensen HT.

Br J Cancer. 2010 Sep 28;103(7):947-53. doi: 10.1038/sj.bjc.6605883. Epub 2010 Sep 14.


Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis.

Cronin-Fenton DP, Murray LJ, Whiteman DC, Cardwell C, Webb PM, Jordan SJ, Corley DA, Sharp L, Lagergren J; Barrett's Esophagus, Adenocarcinoma Consortium (BEACON) Investigators.

Eur J Cancer. 2010 Jul;46(11):2067-76. doi: 10.1016/j.ejca.2010.03.032. Epub 2010 Apr 22.


Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study.

Cronin-Fenton DP, Pedersen L, Lash TL, Friis S, Baron JA, Sørensen HT.

Breast Cancer Res. 2010;12(2):R15. doi: 10.1186/bcr2482. Epub 2010 Mar 1.


Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in northern Denmark.

Chang ET, Cronin-Fenton DP, Friis S, Hjalgrim H, Sørensen HT, Pedersen L.

Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):59-64. doi: 10.1158/1055-9965.EPI-09-0909.


No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medications.

Ahern TP, Pedersen L, Cronin-Fenton DP, Sørensen HT, Lash TL.

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2562-4. doi: 10.1158/1055-9965.EPI-09-0516. Epub 2009 Aug 18.


Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland.

Sharp L, Carsin AE, Cronin-Fenton DP, O'Driscoll D, Comber H.

Eur J Cancer. 2009 May;45(8):1450-9. doi: 10.1016/j.ejca.2009.01.033. Epub 2009 Mar 4.


Inequity in colorectal cancer treatment and outcomes: a population-based study.

Carsin AE, Sharp L, Cronin-Fenton DP, Céilleachair AO, Comber H.

Br J Cancer. 2008 Jul 22;99(2):266-74. doi: 10.1038/sj.bjc.6604467. Epub 2008 Jul 1.


Treatment and survival in a population-based sample of patients diagnosed with gastroesophageal adenocarcinoma.

Cronin-Fenton DP, Mooney MM, Clegg LX, Harlan LC.

World J Gastroenterol. 2008 May 28;14(20):3165-73.


Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study.

Friis S, Thomassen L, Sørensen HT, Tjønneland A, Overvad K, Cronin-Fenton DP, Vogel U, McLaughlin JK, Blot WJ, Olsen JH.

Eur J Cancer Prev. 2008 Apr;17(2):88-96. doi: 10.1097/CEJ.0b013e3282b6fd55.


Survival in Danish patients with breast cancer and inflammatory bowel disease: a nationwide cohort study.

Søgaard KK, Cronin-Fenton DP, Pedersen L, Sørensen HT, Lash TL.

Inflamm Bowel Dis. 2008 Apr;14(4):519-25.


Trends in breast-conserving surgery in Denmark, 1982-2002.

Ahern TP, Larsson H, Garne JP, Cronin-Fenton DP, Sørensen HT, Lash TL.

Eur J Epidemiol. 2008;23(2):109-14. Epub 2007 Nov 7.


Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement.

Cronin-Fenton DP, Ries LA, Clegg LX, Edwards BK.

J Natl Cancer Inst. 2007 Jul 4;99(13):1044-9. Epub 2007 Jun 27.


Comorbidity and survival of Danish breast cancer patients from 1995 to 2005.

Cronin-Fenton DP, Nørgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, Sørensen HT.

Br J Cancer. 2007 May 7;96(9):1462-8. Epub 2007 Apr 3.


Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: a population-based study.

Cronin-Fenton DP, Sharp L, Carsin AE, Comber H.

Eur J Cancer. 2007 Feb;43(3):565-75. Epub 2006 Nov 30.


Treatment and survival for non-Hodgkin's lymphoma: influence of histological subtype, age, and other factors in a population-based study (1999-2001).

Cronin-Fenton DP, Sharp L, Deady S, Comber H.

Eur J Cancer. 2006 Nov;42(16):2786-93. Epub 2006 Aug 23.


Supplemental Content

Loading ...
Support Center